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INTRODUCTION
Since Kaznelson suggested the possibility of splenectomy
as a treatment for immune thrombocytopenic purpura (ITP),
laparoscopic splenectomy (LS) has been an important treat-
ment for ITP with the introduction of laparoscopic techni-
ques for splenectomy (1, 2). 
In ITP, it has been known that the spleen plays a central
role in the pathophysiologic process. The spleen is not only
the place to produce auto-antibodies for self platelets, but also
the site where the platelet-antibody complexes are destroyed.
The medical therapy based on steroids is the first choice of
treatment, and surgical intervention, splenectomy, is reserved
for the cases of refractoriness for medical treatment, depen-
dence on steroids, and complications from medical treatment.
ITP accounts for more than 60% of the total indication
for LS (3-6), and the response rate for LS has been reported
from 50% to 80% (1, 7, 8). However, in general, follow-up
periods after LS has not been long enough and operative com-
plications were limited to perioperative complications and
overwhelming postsplenectomy infection (OPSI), which give
just limited information about long-term outcomes after LS
for ITP (1-4, 7, 8). 
We have already reported early experiences of LS in patients
with ITP (8) and the long-term results, of which the num-
ber of total patients was 40 and the mean follow-up duration
was 29 months (2). With further experiences of LS in ITP,
we investigated long-term outcomes of LS, newly developed
morbidities, and predictive factors for favorable outcomes
comparing the data to previous studies (2, 8).
MATERIALS AND METHODS
We reviewed the available medical records of 88 patients
with ITP who underwent LS from August 1994 to Decem-
ber 2004 in Yonsei Medical Center, Seoul, Korea. Among
them, available medical records of 59 patients whose follow-
up period was more than 1 yr were investigated. We described
the results of LS into the categories of early results and late
results (2, 8), and we followed up patients based on out-pa-
tients’ medical records and standardized personal question-
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Long-term Follow-up of Laparoscopic Splenectomy in Patients with
Immune Thrombocytopenic Purpura 
Laparoscopic splenectomy (LS) has been reserved for intractable and relapsing
immune thrombocytopenic purpura (ITP) despite medical treatment. With further
experiences of LS in ITP, we investigated long term outcomes of LS, especially
newly developed morbidities, and tried to find predictive factors for favorable out-
comes. From August 1994 to December 2004, fifty-nine patients whose follow-up
period was more than 12 months after LS were investigated. After a long-term fol-
low-up (median 54 months, range 12.5-129 months), a complete response (CR)
was found in 28 patients (47.5%), partial response in 24 (40.7%), and no response
in 7 (11.9%). The relapse rate during follow-up periods was 15.2%. The rapid res-
ponse group (p=0.017), in which the platelet count increased more than twice of
the preoperative platelet count within 7 days after LS, relapsing after medical treat-
ment (p=0.02), and the satisfactory group as the initial result of LS (p=0.001) were
significant for predicting CR in univariate analysis, but only the initial satisfactory group
was an independent predictive factor for CR in multivariate analysis (p=0.036, rel-
ative risk=6419; 95% CI, 1.171-35.190). Infections were the most frequent morbidi-
ties during the follow-up period, which were treated well without mortality. LS is a
safe and effective treatment modality for ITP. Active referral to surgery might be re-
quired, considering complications and treatment results related to long-term use of
steroid-based medications.
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naires conducted by personal telephone when medical records
were not available. 
Defining treatment results of LS and predictable factors
Early results of LS were classified as in the following man-
ner. We defined patients as the satisfactory group (S) when
their platelet count after LS was more than 150,000/ L with
a tapering dose of steroid or without medication on discharge.
To the contrary, patients whose platelet count was less than
150,000/ L or without a tapering dose of medication on dis-
charge were defined as the unsatisfactory group (US).
We categorized follow-up results according to this crite-
ria: 1) during the long term follow-up, if the patient’s platelet
count after LS was over 150,000/ L with neither medication
nor bleeding symptoms for more than 2 months, then we
considered the patients as showing complete response (CR);
2) partial response (PR) was the term used where LS result-
ed in patients’ platelet counts over 50,000/ L with a smaller
dose of steroid than preoperative; 3) no response (NR) was
used to describe patients in whom LS resulted in no response
or a platelet count increasing to less than 50,000/ L with the
therapeutic dose of medication; 4) we regarded patients as
relapsing when, among the patients in the early satisfactory
group, patients’ platelet count became less than 100,000/ L
and resumed medical treatment during follow-up.
To facilitate the statistical analysis of the data, we also made
other variables as follows: 1) rapid response group, patients
whose postoperative platelet count increased more than twice
of preoperative platelet counts within the 7th postoperative
day, 2) slow response group, patients who did not belong to
the category of the rapid response group. We also categorized
our data based on clinical characteristics and investigated the
predicting factors for CR.
Data analysis
Statistic analysis was carried out with SPSS, version 10.0.
Differences were evaluated by the chi-square test and Stu-
dent’s t-test. A p value less than 0.05 was considered as sta-
tistically significant. The variables found to be significantly
related to favorable outcomes (complete remission) were sub-
sequently evaluated with multiple logistic regression analysis.
RESULTS
General characteristics
The median age of the patients (51 women and 8 men) was
32 yr (range, 18-70 yr). Thirty-one (52.5%) patients had asso-
ciated diseases. Metabolic disease, including diabetes, was the
most common among them, and systemic lupus erythemato-
sus (SLE) was combined with ITP in 3 patients. Six patients
had previous abdominal surgery, 4 had appendectomies, and
2 had salphingo-oohoprectomy. The median platelet count
at the time of diagnosis of ITP was 36,000/ L (range, 30,000-
99,000/ L). Thirty-one (55.4%) patients took only steroids
as medical treatment, and 25 patients (44.6%) received a
combined medical regimen, including danazole, vincristine,
cyclosphorine. With regard to the indication of LS, medical
refractoriness were found in 31 patients (55.4%), relapsing
during the course of tapering medication in 26 (medical rela-
psing, 46.4%), and complications of medical treatment such
as weight gain, general weakness, acne, cushing appearance
in 23 (medical complication, 41.1%). Median follow-up peri-
ods in the Department of Medicine before surgery was 7 mon-
ths (range, 0.5-74 months).
Operative results
The median operation time was 125 min (range, 65-250
min). Accessory spleens were found in 8 patients (13.6%).
Among them, 2 patients were found to have accessory spleens
on the spleen scan done for evaluation of relapse after LS, which
































Fig. 2. Follow-up results of laparoscopic splenectony in immune
thrombocytopenic purpura.
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conversed to open splenectomy. Two cases of conversion were
caused by uncontrolled bleeding during the dissection of the
splenic hilum, the other one was by the loss of spleen in the
delivery process of the specimen. The median spleen weight
was 135 g (range, 37-260 g), and postoperative drain was used
in 40 patients (78.1%). Patients’ oral intake began on median
postoperative d2 after LS (range, 0-6 days). Complications
related to LS were found in 6 patients (10.9%) and 7 com-
plications were observed. Postoperative bleeding was found
in 2, patients, abdominal abscess in 2, wound infection in 2
and electric burn injury to the small bowel leading to segmen-
tal resection in 1 patient.
Early and late results of LS
Early results of LS showed that 32 patients (54.2%) were
in the satisfactory group (S) and 26 patients (44.1%) in unsat-
isfactory group (US) (Fig. 1).
Among 88 patients, 59 patients were followed up for more
than one year (median 54 months; range, 12.5-129 months;
follow-up rate, 67.5%). With regard to late results of LS, 28
patients (47.5%) were categorized as CR, 24 patients (40.7
%) as PR, and 7 patients (11.9%) as NR (Fig. 2).
Nine (15.2%) patients, among patients in early satisfac-
tory group, had relapsed during the follow-up period. When
looking into the pattern of relapsing, single relapsing was
found in 6 (66.6%) patients and relapsing more than twice
in 3 (33.3%). 
Determination of prognostic factors for complete remission
The clinical and laboratory variables were examined by uni-
variate analysis (chi-square) in relation to the achievement
of CR after long-term follow-up. Three variables were found
to have a prognostic value for CR in univariate analysis (Table
1). The rapid response group (p=0.017), in which the platelet
count increased more than twice of the preoperative platelet
count within 7 days after LS, relapsing after medical treatment
in preoperative setting (medical relapsing, p=0.02), and the
satisfactory group as an initial result of LS (p=0.001) were
statistically significant in predicting CR after LS. These indi-
vidually significant prognostic variables were subsequently
included in multiple logistic regression analysis, which re-






Male 7 3 4 NS
Female 44 22 22
Age (yr) 39.2±12.4 36.1±13.4 NS
Pregnancy
No 42 18 24 NS
Yes 9 7 2
Incidental diagnosis
No 19 16 8 NS
Yes 31 14 17
Medical refractoriness
No 22 10 14 NS
Yes 24 14 10
Medical relapsing
No 22 15 7 0.02
Yes 26 9 17
Medical complication
No 27 12 15 NS
Yes 21 12 9
Rapid response group
No 25 16 9 0.017
Yes 21 6 15
Early result
US 24 18 6 0.001
S2 6 7 1 9
Preop. IVIG
No 19 9 10 NS
Yes 23 12 11
Accessory spleen
No 40 20 20 NS
Yes 5 2 3
Spleen weight (g) 126.2±64.3 121.6±45.1
Medical follow-up (month) 15.6±18.4 18.1±22.1 NS
PLT at diagnosis. (×10
3/ L) 39.2±25.7 29.3±25.5 NS
Preoperative PLT (×10
3/ L) 74.1±57.8 11.2±75.9 NS
Medical regimen
Steroid only 31 25 6 NS
Steroid+others 25 22 3
Preop. PLT transfusion
No 18 9 9 NS
Yes 27 13 14






Medical relapsing 3.968 0.939-16.758 0.061
Early result 6.419 1.171-35.190 0.032
Rapid response 1.576 0.287-8.650 0.601
Table 2. Logistic mutivariable regression analysis
SLE, systemic lupus erythematosus.
Frequency








Table 3. Newly developed health problems after laparoscopic
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vealed that only the initial satisfactory group (p=0.036, rel-
ative risk=6,419; 95% CI, 1.171-35.190) after LS was an
independent prognostic factor for CR (Table 2).
Newly developed health problems during follow-up 
During the follow-up period after LS, infection was the
most common newly developed problem (Table 3). This in-
cluded 5 cases of pneumonia, 2 cases of viral infection, such
as herpes zoster and human polioma virus, 1 case of fungal
sinusitis, 1 case of aseptic meningitis, and 1 case of tubercu-
losis pleurisy. Avascular necrosis of the head of femur, periph-
eral neuropathy, SLE, pulmonary thromboembolism, benign
masses in the thyroid, breast, and ovary were also noted.
DISCUSSION
Previous reports on long-term results of LS in ITP had
somewhat limited follow-up periods, making it difficult to
exactly define the long-term outcome of LS for ITP (2, 3, 7,
8). According to our data, the early result of LS reveals that
54.2% of patients belonged to the satisfactory group, and
the late follow-up results showed that CR was 47.5%, PR
was 40.7%, and NR was 11.9%. These results of CR were
dependent upon the criteria of patients’ platelet count (more
than 150,000/ L), clinical symptoms, and the status of medi-
cal treatment. However, from the clinical point of view, many
heterogeneous patients compose the PR group according to
these criteria. In other words, some patients with their platelet
counts between 100,000/ L and 150,000/ L without med-
ical treatment and no bleeding symptoms belonged to the
PR group where most patients with their platelet counts
more than 50,000/ L with medical treatment and bleeding
symptoms. Considering these weak points of the criteria used
in this study, the clinical results of LS in ITP can be re-esti-
mated as follows: when we define 100,000/ L as the point
for favorable outcome, 42 patients (72.4%) belonged to the
satisfactory group and 16 (27.6%) to the unsatisfactory group;
likewise, CR was 66.1% (39 patients), PR was 22% (13 pa-
tients), and NR was 11.9% (7).
Other researchers suggested that age, response to preoper-
ative medical treatment, the period from the diagnosis of ITP
to splenectomy, and the degree of platelet response after sple-
nectomy are known as predictive factors for favorable out-
comes of splenectomy in ITP. Our previous study (2) on this
issue revealed that the rapid response group had a predictive
value in univariate analysis, whose platelet counts after LS
increased more than twice within a week. This rapid response
group also had a significant value for predicting favorable
outcomes (CR) in this study. Therefore, a current follow-up
study could confirm the meaning of the rapid response group
for predicting favorable long-term results after LS in ITP.
In the current study, one of the indications of splenectomy
in ITP, that is, relapsing cases (‘‘medical relapsing’’) during
the tapering does of medication, was another predictive value
in univariate analysis (p=0.02, Table 1). Multiple regression
analysis showed that medical relapsing can predict favorable
outcomes after LS and its relative risk was about 4 times (Exp
(B)=3.968, p-value=0.061, 95% CI: 0.939-16.758). Even
though the p-value was not less than 0.05, we expect this
value could be significant if enough patients’ data were col-
lected. Long-term medical treatment can make the patients
exhausted and reduce the quality of life. Taking the fact that
the patients’ population was mostly female and also the side-
effects of long-term medical treatment into consideration,
this result suggests that patients with relapses after medical
treatment need to be referred to the Department of Surgery
for LS without further medical treatment. Recent observa-
tion performed by Kwon et al. (9) supports this suggestion.
Based on 30 LS on patients with ITP, they concluded that
splenectomy for steroid nonresponders resulted in inferior
response rates as compared with those who experienced relapse
after steroid treatment (55.6% vs. 91.7%, p=0.042), and
the time between diagnosis and surgery is another predictive
factor for favorable outcomes (p=0.049).
Another predictive factor for favorable outcome is the early
result of LS. The satisfactory group is the most potent and
independent predictive factor in our study (Exp (B)=6.419,
p=0.032, 95% CI: 1.171-35.190). In fact, 9 patients (15.2%)
had relapsed with their platelet count less than 100,000/ L
and took medications again, which is not very different from
other reports (7, 10). Most patients with cases of relapse took
steroids combined with various doses of danazole, vincristine,
immuran, and cyclosporine. On the other hand, the rest (84.8
% patients in the satisfactory group) could be categorized
into CR without any relapsing or any additional medications.
This result can address the notion that early satisfactory res-
ponse after LS in ITP can be sustained for a prolonged time
without relapsing, which means that LS is a very effective
treatment modality in ITP.
Accessory spleen has been regarded as an important factor
causing relapsing when not adequately removed in LS (11).
However, current results showed only two relapsing patients
revealed to have accessory spleen. After excising all accessory
spleen, both patients belonged to PR. This result could not
explain the accessory spleen itself and is only responsible for
relapsing after splenectomy. Considering other articles show-
ing that only 25-75% of patients had good results after the
excise of accessory spleen (5, 12), our result suggests that other
possible mechanisms might be related to the recurrence after
LS, such as sequestration of platelets in marrow or liver, not
to mention the accessory spleen itself (13).
With respect to newly developed health problems observed
during follow-up periods, infectious diseases were most com-
monly discovered in 10 patients. The overall incidence of
septicemia is low in adults, but death rates from OPSI have
been reported to be up to 600 times greater than in the gen-424 C.M. Kang, J.G. Lee, K.S. Kim, et al.
eral population, with a lifetime risk for OPSI of 5% (14).
Though almost all patients did not receive a preoperative
vaccination in our study, fatal infectious disease was, fortu-
nately, not found. However, pneumonia occurred in 5 pati-
ents, who were admitted to hospital to receive proper man-
agement. We consider that much efforts should be made for
safe LS and the prevention of OPSI. So, we have recently start-
ed a preoperative vaccination against pneumococcus and H.
influenza prior to splenectomy. In addition, we recommend
that those patients who underwent LS get vaccinated for
influenza annually based on the clinical experiences that the
patients who underwent LS seem to often contract common
colds. The common cold might play roles in triggering sec-
ondary pulmonary bacterial infection. We believe the edu-
cation of patients over the status of patients’ immunity is
important. They should be informed of the necessity for fol-
low-up especially when their infectious symptoms are not
alleviated for a long time and become even more aggravat-
ing. These strategies are compatible with the 2001 guide-
lines for preventing OPSI (15). On the issue of prophylactic
antibiotics to prevent OPSI, however, we do not have confi-
dence in this policy since patients’ compliance, the uncertain
efficacy of prophylactic antibiotics, and the emergence of
antibiotics resistance bacteria, should be considered.
An increased incidence of atherosclerotic events, such as
cerebrovascular accident and heart disease, have been report-
ed after splenectomy because abnormal erythrocytes may
remain longer in the circulatory system, initiating platelet
activation, as well as thrombocytosis after splenectomy (1).
In our data, just one patient experienced pulmonary throm-
boembolism. This patient had SLE at the time of the diag-
nosis of ITP. However, this case was concluded to be related
to antiphospholipid syndrome in SLE patients based on lab-
oratory and patients’ history as reported in other articles (16).
Avascular necrosis of the femur head and peripheral neu-
ropathy are believed to be related to long-term use of medi-
cations prior to LS, such as steroid and vincristine. Hence we
would like to recommend LS as early as possible in patients
with ITP in order to reduce the complications related to long-
term use of medication. Especially with the advancement of
laparoscopic skill and experiences, we recently have been per-
forming LS with a three-port method, and with a very low
rate of complications. According to our data, the median oper-
ative time was 77.5 min (range, 60-115 min), and the medi-
an length of hospital stay has been 4 days after surgery (range,
2-11 days) since 2001.
In summary, we are sure that LS is a very effective and safe
treatment for ITP based on our long-term follow-up results.
The initial satisfactory group after LS is a potent independent
predictive factor for favorable outcomes. Long-term follow-
up is necessary because of not only relapsing but also newly
developed health problems after LS such as infection and other
clinically important issues.
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